Different ART outcomes at increasing peak estradiol levels with long and antagonist protocols: Retrospective insights from ten years experience

Journal of Assisted Reproduction and Genetics

Volumn 28, Issue 8, 2011, Pages 693-698

  Manno, Massimo ^a   Cervi, Marta ^a   Zadro, Donatella ^a   Fuggetta, Giuseppa ^a   Adamo, Valter ^a   Tomei, Francesco ^a  

^a Pordenone Hospital   (Italy)

Author keywords

Endometrium; GnRH agonists; GnRH antagonists; Implantation rate; Peak estradiol levels; Pregnancy rate

Indexed keywords

ESTRADIOL;

ADULT; ARTICLE; CLINICAL EVALUATION; CONTROLLED OVARIAN STIMULATION; FEMALE; FEMALE INFERTILITY; HORMONAL THERAPY; HUMAN; IMPLANTATION; INFERTILITY THERAPY; OOCYTE; OUTCOME ASSESSMENT; PREGNANCY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; EMBRYO IMPLANTATION; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HUMANS; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY RATE; REPRODUCTIVE TECHNIQUES, ASSISTED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 80755140466     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-011-9570-4     Document Type: Article

References (28)

1. Valbuena D, Martin J, de Pablo JL, Remohi J, Pellicier A, Simon C. Increasing levels of estradiol are deleterious to embryonic implantation because the directly affect the embryo. Fertil Steril. 2001; 76: 962-8. (Pubitemid 33031323)
2. Mitwally MFM, Bhakoo HS, Crickard K, Sullivan M, Batt RE, Yeh J. Estradiol production during controlled ovarian hyperstimulation correlates with treatment outcome in women undergoing in vitro fertilization-embryo transfer. Fertil Steril. 2006; 86: 588-96. (Pubitemid 44307001)
3. Kosmas IP, Kolibianakis EM, Devroey P. Association of estradiol levels on the day of HCG administration and pregnancy achievement in IVF: a systematic review. Hum Reprod. 2004; 19: 2446-53. (Pubitemid 39481265)
4. Lee FK, Lai TH, Lin TK, Horng SG, Chen SC. Relationship of progesterone/estradiol ratio on day of HCG administration and pregnancy outcomes in high responders undergoing in vitro fertilization. Fertil Steril. 2009; 92: 1284-9.
5. Kim YJ, Ku SY, Jee BC, Suh CS, Kim SH, Choi YM, et al. Dynamics of early estradiol production may be associated with outcomes of in vitro fertilization. Fertil Steril. 2010; 94: 2868-70.
6. Arslan M, Bocca S, Arslan EO, Duran HE, Stadtmauer L, Oehninger S. Cumulative exposure to high estradiol levels during the follicular phase of IVF cycles negatively affects implantation. J Assist Reprod Genet. 2007; 24: 111-7. (Pubitemid 46643904)
7. Horcajadas JA, Minguez P, Dopazo J, Esteban FJ, Domingues F, Giudice LC, et al. Controlled ovarian stimulation induces a functional genomic delay of endometrium with potential clinical implications. J Clin Endocrinol Metab. 2008; 93: 4500-10. (Pubitemid 352789553)
8. Haouzi D, Assou S, Dechanet C, Anahory T, Dechaud H, De Vos J, et al. Controlled ovarian hyperstimulation for in vitro fertilization alters endometrial receptivity in humans: protocols effect. Biol Reprod. 2010; 82: 679-86.
9. Strowitzki T, Germeyer A, Popovici R, von Wolff M. The human endometrium as fertility-determining factor. Hum Reprod Update. 2006; 12: 617-30.
10. Haouzi D, Assou S, Mahmoud K, Tondeur S, Reme T, Hedon B, et al. Gene expression profile of human endometrial receptivity: comparison between natural and stimulated cycles for the same patients. Hum Reprod. 2009; 24: 1436-45.
11. Martinez-Conejero JA, Simon C, Pellicer A, Horcajadas JA. Is ovarian stimulation detrimental to the endometrium? Reprod Biomed Online. 2007; 15: 45-50.
12. Rubio C, Mercader A, Alama P, Lizan C, Rodrigo L, Labarta E, et al. Prospective cohort study in high responder oocyte donors using fstwo hormonal stimulation protocols: impact on embryo aneuploidy and development. Hum Reprod. 2010; 25: 2290-7.
13. Kyrou D, Popovic-Todorovic B, Fatemi HM, Bourgain C, Haentjens P, Van Landuyt L, et al. Does the estradiol level on the day of human chorionic gonadotropin administration have an impact on pregnancy rates in patient treated with rec-FSH/GnRH antagonist? Hum Reprod. 2009; 24: 2902-9.
14. Makkar G, Ng EHY, Yeung WSB, Ho PC. Reduced expression of interleukin-11 and interleukin-6 in the periimplantation endometrium of excessive ovarian responders during in vitro fertilization treatment. J Clin Endocrinol Metab. 2006; 91: 3181-8. (Pubitemid 44274801)
15. Liu Y, Kodithuwakku SP, Ng PY, Chai J, Ng EHY, Yeung WSB, et al. Excessive ovarian stimulation up-regulates the Wntsignaling molecule DKKI in human endometrium and may affect implantation: an in vitro co-culture study. Hum Reprod. 2010; 15: 479-90.
16. Bodri D, Sunkara SK, Coomarasamy A. Gonadotropin-releasing hormone agonists versus antagonists for controlled ovarian hyperstimulation in oocyte donors: a systematic review and meta-analysis. Fertil Steril. 2010 Aug 3 [Epub ahead of print].
17. Van der Gaast MH, Eijkemans MJ, van der Net JB, de Boer EJ, Burger CW, van Leeuwen FE, et al. Optimum number of oocytes for a successful first IVF treatment cycle. Reprod Biomed Online. 2006; 13: 476-80. (Pubitemid 44548781)
18. Simon C, Garcia Velasco JJ, Valbuena D, Peinado JA, Moreno C, Remohi J, et al. Increasing uterine receptivity by decreasing estradiol levels during preimplantation period in high responders with the use of a follicle-stimulating hormone step-down regimen. Fertil Steril. 1998; 75: 525-31.
19. Nelson SM, Yates RW, Lyall H, Jamieson M, Traynor I, Gaudoin M, et al. Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception. Hum Reprod. 2009; 24: 867-75.
20. Orvieto R, Meltzer S, Rabison J, Zohav E, Anteby EY, Nahum R. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity. Fertil Steril. 2008; 90: 1294-6.
21. Aflatoonian A, Oskouian H, Ahmadi S, Oskouian L. Can fresh embryo transfers be replaced by cryopreserved-thawed embryo transfers in assisted reproductive cycles? A randomized controlled trial. J Assist Reprod Genet. 2010; 27: 357-63.
22. Brandes M, Verzijden JCM, Hamilton CJCM, de Weys NPC, de Bruin JP, Bots RSGM et al. Is the fertility treatment itself a risk factor for early pregnancy loss? Reprod Biomed Online. 2010 [Epub ahead of print].
23. Melo M, Busso CE, Bellver J, Alama P, Garrido N, Meseguer M, et al. GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controller, assessor-blind study. Reprod Biomed Online. 2009; 19: 486-92.
24. Griesinger G, Kolibianakis EM, Papanikolau EG, Diedrich K, Van Steirteghem A, Devroey P, et al. Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles. Fertil Steril. 2007; 88: 616-21. (Pubitemid 47368245)
25. Humaidan P, Bredkjaer HE, Westergaard LG, Andersen CY. 1500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study. Fertil Steril. 2009; 93: 847-54.
26. Youssef M, Van der Veen F, Al-Inhany HG, Griesinger G, Mochtar MH, van Wely M. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles (Review). Cochrane. 2010 issue 11.
27. Griesinger G, Berndt H, Schultz L, Depenbush M, Schultze- Mosgau A. Cumulative live birth rates after GnRH-agonist triggering of final oocyte maturation in patients at risk of OHSS: a prospective, clinical cohort study. Eur J Obstet Gynecol Reprod Biol. 2010; 149: 190-4.
28. Herrero H, Pareja S, Losada C, Cobo AC, Pellicer A. Avoiding the use of human chorionic gonadotropin combined with oocyte vitrification and GnRH agonist triggering versus coasting. A new strategy to avoid ovarian hyperstimulation syndrome. Fertil Steril. 2010 [Epub ahead of print].